GLENMARK LIFE SCIENCES
|
The Current P/S Ratio of GLENMARK LIFE SCIENCES is 5.54.
Share Price | ₹1,029.3 | Feb 18,2025 |
Market Cap | ₹12,608.3 Cr | |
Sales-TTM | ₹2,273.9 Cr | TTM-Standalone Results |
Price/Sales | 5.54x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLENMARK LIFE SCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹12,608.3 Cr] as on Feb 18,2025
(/) Sales [ ₹2,273.9 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 5.54x ]
Thus, for GLENMARK LIFE SCIENCES , the investors are currently willing to pay '5.54 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLENMARK LIFE SCIENCES !
The chart below summarizes the trend in P/S Ratio of GLENMARK LIFE SCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of GLENMARK LIFE SCIENCES
PS Ratio Performance Analysis for GLENMARK LIFE SCIENCES
- GLENMARK LIFE SCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.81x.
- GLENMARK LIFE SCIENCES 's operated at median p/e ratio of 2.22x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLENMARK LIFE SCIENCES 's p/e ratio peaked in Mar2024 at 4.16x.
- GLENMARK LIFE SCIENCES 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does GLENMARK LIFE SCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLENMARK LIFE SCIENCES | 2,273.9 | 5.54 | 12,608.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.91 | 408,259.0 |
CIPLA LTD | 26,981.2 | 4.44 | 119,705.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.20 | 99,953.9 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.13 | 91,889.3 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.07 | 154,917.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.46 | 98,468.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.12 | 103,101.0 |
LUPIN LTD | 22,001.6 | 4.18 | 91,887.3 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.19 | 67,608.2 |
ABBOTT INDIA LTD | 6,243.2 | 9.98 | 62,299.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLENMARK LIFE SCIENCES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.19x |
Max industry PS | 17.07x |
Median industry PS | 5.54x |
Average industry PS | 6.93x |
You may also like the below Video Courses